LogicBio Therapeutics, Inc. EPS - Earnings per Share 2018-2022 | LOGC
LogicBio Therapeutics, Inc. eps - earnings per share from 2018 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| LogicBio Therapeutics, Inc. Annual EPS |
| 2021 |
$-1.24 |
| 2020 |
$-1.29 |
| 2019 |
$-1.78 |
| 2018 |
$-3.04 |
| 2017 |
$-5.54 |
| LogicBio Therapeutics, Inc. Quarterly EPS |
| 2022-09-30 |
$-0.18 |
| 2022-06-30 |
$-0.15 |
| 2022-03-31 |
$-0.20 |
| 2021-12-31 |
$-0.28 |
| 2021-09-30 |
$-0.31 |
| 2021-06-30 |
$-0.33 |
| 2021-03-31 |
$-0.32 |
| 2020-12-31 |
$-0.19 |
| 2020-09-30 |
$-0.34 |
| 2020-06-30 |
$-0.35 |
| 2020-03-31 |
$-0.41 |
| 2019-12-31 |
$-0.51 |
| 2019-09-30 |
$-0.48 |
| 2019-06-30 |
$-0.45 |
| 2019-03-31 |
$-0.34 |
| 2018-12-31 |
$7.93 |
| 2018-09-30 |
$-4.03 |
| 2018-06-30 |
$-4.19 |
| 2018-03-31 |
$-2.75 |
| 2017-09-30 |
$-1.55 |
